Table 2

Effects of DBSP, TCA, octreotide, and PAH on Kp values in SDRs and Kp values in EHBRs of [14C]octreotide and [3H]inulin 5 min after intravenous bolus injection of [14C]octreotide and [3H]inulin

ControlDBSPTCAoctreotidePAHEHBR
[14C]Octreotide
 Liver2.417  ± 0.1400.466  ± 0.0102-a 0.453  ± 0.0942-a 1.235  ± 0.2802-a 2.340  ± 0.3260.692  ± 0.0232-a
 Kidney5.263  ± 0.2194.996  ± 0.0934.402  ± 0.1783.600  ± 1.7733.815  ± 0.3042-a 4.681  ± 0.472
 Intestine0.279  ± 0.0070.237  ± 0.0022-a 0.234  ± 0.0022-a 0.262  ± 0.0140.266  ± 0.0080.230  ± 0.020
 Pancreas0.375  ± 0.0750.300  ± 0.0150.270  ± 0.0070.186  ± 0.0060.336  ± 0.0200.287  ± 0.028
 Lung0.661  ± 0.0100.581  ± 0.0082-a 0.556  ± 0.0172-a 0.643  ± 0.0420.616  ± 0.0180.575  ± 0.0052-a
 Muscle0.153  ± 0.0370.104  ± 0.0010.097  ± 0.0060.125  ± 0.0340.127  ± 0.0020.110  ± 0.009
 Spleen0.287  ± 0.0050.276  ± 0.0050.270  ± 0.0350.328  ± 0.0300.315  ± 0.0062-a 0.289  ± 0.009
 Cerebrum0.011  ± 0.0000.010  ± 0.0000.010  ± 0.0010.009  ± 0.0000.012  ± 0.0010.011  ± 0.000
 Cerebellum0.014  ± 0.0010.014  ± 0.0000.013  ± 0.0010.014  ± 0.0010.017  ± 0.0000.015  ± 0.001
[3H]Inulin
 Liver0.171  ± 0.0070.173  ± 0.0070.206  ± 0.0120.156  ± 0.0090.179  ± 0.0040.173  ± 0.011
 Kidney9.201  ± 1.4078.141  ± 0.9499.406  ± 0.2977.380  ± 4.9136.865  ± 0.40212.033  ± 2.763
 Intestine0.214  ± 0.0120.235  ± 0.0070.255  ± 0.0092-a 0.195  ± 0.0310.221  ± 0.0080.238  ± 0.023
 Pancreas0.250  ± 0.0080.224  ± 0.0090.226  ± 0.0240.221  ± 0.0160.235  ± 0.0260.226  ± 0.003
 Lung0.431  ± 0.0170.425  ± 0.0070.429  ± 0.0020.373  ± 0.0370.401  ± 0.0270.367  ± 0.069
 Muscle0.166  ± 0.0070.182  ± 0.0040.169  ± 0.0090.094  ± 0.0192-a 0.214  ± 0.0122-a 0.275  ± 0.049
 Spleen0.195  ± 0.0130.199  ± 0.0120.206  ± 0.0280.191  ± 0.0170.193  ± 0.0080.236  ± 0.017
 Cerebrum0.022  ± 0.0020.024  ± 0.0020.023  ± 0.0010.020  ± 0.0020.020  ± 0.0010.021  ± 0.001
 Cerebellum0.024  ± 0.0010.026  ± 0.0010.025  ± 0.0010.022  ± 0.0010.022  ± 0.0010.025  ± 0.002
  • 2-a Significant diference from control (p < 0.05).